Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biopharma crawled time : 12:15 save search
9 Meters Biopharma, Inc. Presents Pharmacokinetic Data at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
Published: 2021-10-26 (Crawled : 12:15) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -2.65%
H: 0.0%
C: 0.0%
biopharma
$2.3 Bn Pharmaceuticals & Biopharmaceuticals Continuous Manufacturing Markets, 2027
Published: 2021-09-29 (Crawled : 12:15) - prnewswire.com
LZAGF | $558.779 -19.1% 23
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
LZAGY | $57.57 0.02% 93K
|
Professional, Scientific, and T...
|
| O: 1.05%
H: 0.09%
C: -1.56%
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: 0.58%
H: 1.14%
C: 0.29%
GLW 4 | $31.52 -0.03% 0.0% 3.2M
|
Electronic Technology
|
| O: 0.11%
H: 0.61%
C: -1.38%
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
|
| O: 0.7%
H: 1.51%
C: -1.19%
AVTR | $25.46 -0.74% 0.0% 4.8M
|
Process Industries
|
| O: 1.09%
H: 1.71%
C: -0.05%
RGEN | $167.71 -2.08% -2.16% 550K
|
Health Technology
|
| O: 0.89%
H: 2.93%
C: -0.67%
biopharma
Landos Biopharma to Present Results of LABP-104 in Lupus at the American College of Rheumatology Convergence 2021
Published: 2021-09-15 (Crawled : 12:15) - globenewswire.com
LABP | $22.21 0.27% 0.27% 9.1K
|
|
| O: 1.01%
H: 14.53%
C: 10.09%
biopharma results lupus
RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients
Published: 2021-09-14 (Crawled : 12:15) - prnewswire.com
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: -32.93%
H: 7.07%
C: 0.4%
covid phase 2 biopharma phase 2/3 opaganib topline
POINT Biopharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-07 (Crawled : 12:15) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.56%
H: 2.33%
C: -2.33%
biopharma conference
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights
Published: 2021-08-26 (Crawled : 12:15) - biospace.com/
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: 4.46%
H: 3.33%
C: -2.8%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: -0.62%
H: 1.67%
C: -0.7%
biopharma financial results results
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
ABIO | $3.65 5.99% 98K
|
Health Technology
|
| O: -3.33%
H: 0.69%
C: -4.48%
biopharma
GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results
Published: 2021-08-06 (Crawled : 12:15) - prnewswire.com
GTBP | $3.65 -2.44% 370
|
Manufacturing
|
| O: 0.18%
H: 0.0%
C: -1.86%
biopharma results conference
Navidea Biopharmaceuticals to Host Second Quarter 2021 Earnings Conference Call and Business Update
Published: 2021-08-04 (Crawled : 12:15) - biospace.com/
NAVB | $0.0368 50.69% 6.6K
|
Health Technology
|
| O: 1.21%
H: 0.6%
C: 0.6%
biopharma conference
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
Published: 2021-07-08 (Crawled : 12:15) - globenewswire.com
VOR | $1.745 -7.18% -7.74% 290K
|
|
| O: -0.77%
H: 13.83%
C: 9.88%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.42%
H: 0.45%
C: 0.23%
biopharma myeloid leukemia stem cell therapy collaboration announces collaboration antibody leukemia acute myeloid leukemia aml
Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection
Published: 2021-06-29 (Crawled : 12:15) - biospace.com/
ABUS | $2.74 -0.36% -0.36% 340K
|
Health Technology
|
| O: -0.89%
H: 0.6%
C: -5.69%
hepatitis biopharma collaboration injection infections chronic hepatitis b
Kinnate Biopharma Inc. Appoints Helen Sabzevari, Ph.D. to Board of Directors
Published: 2021-06-28 (Crawled : 12:15) - globenewswire.com
PGEN | $1.42 1.43% 1.41% 560K
|
Health Technology
|
| O: 0.0%
H: 2.05%
C: -2.49%
biopharma
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
Published: 2021-06-14 (Crawled : 12:15) - globenewswire.com
CUE | $1.43 -4.67% -4.9% 320K
|
Health Technology
|
| O: 0.68%
H: 2.54%
C: 1.42%
biopharma life science conference
Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp
Published: 2021-06-11 (Crawled : 12:15) - globenewswire.com
VOR | $1.745 -7.18% -7.74% 290K
|
|
| O: 0.67%
H: 0.0%
C: -5.13%
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: -0.15%
H: 0.36%
C: -1.77%
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: -0.19%
H: 0.56%
C: -0.65%
biopharma
Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC
Published: 2021-06-10 (Crawled : 12:15) - globenewswire.com
CUE | $1.43 -4.67% -4.9% 320K
|
Health Technology
|
| O: 0.84%
H: 3.62%
C: 2.59%
biopharma phase 1 expansion therapy trial phase 3 phase 2
Navidea Biopharmaceuticals Announces Issuance of U.S. Patent for Diagnosis and Treatment of Viral Infections
Published: 2021-05-19 (Crawled : 12:15) - biospace.com/
NAVB | $0.0368 50.69% 6.6K
|
Health Technology
|
| O: 2.94%
H: 0.57%
C: -4.0%
treatment biopharma patent injection diagnostic infections
9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome
Published: 2021-05-17 (Crawled : 12:15) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -0.87%
H: 5.26%
C: 0.88%
biopharma approval syndros designation
Navidea Biopharmaceuticals to Host First Quarter 2021 Earnings Conference Call and Corporate Update
Published: 2021-05-04 (Crawled : 12:15) - biospace.com/
NAVB | $0.0368 50.69% 6.6K
|
Health Technology
|
| O: -1.24%
H: 5.03%
C: 3.14%
biopharma conference
9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit
Published: 2021-04-21 (Crawled : 12:15) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 1.92%
H: 3.77%
C: 1.89%
biopharma life science
Navidea Biopharmaceuticals Announces Acceptance of Therapeutics Focused Abstract for Presentation at the Frontiers in Cancer Immunotherapy Symposium
Published: 2021-04-15 (Crawled : 12:15) - biospace.com/
NAVB | $0.0368 50.69% 6.6K
|
Health Technology
|
| O: -0.6%
H: 5.42%
C: 0.6%
presentation immunotherapy biopharma therapy cancer symposium
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.